Table 2.

Risk factors of disease progression detected at the time of screening

Alcohol consumption n (%) 
AU intake per week 2 (0-35) 
Patient distribution per AU intake per week  
0-6 85 (71) 
7-14 16 (13) 
≥14 14 (12) 
Metabolic  
Type 2 diabetes 8 (6) 
Arterial hypertension 46 (39) 
Dyslipidemia (triglycerides > 150 mg/dL, HDL< 40 mg/dL or need of lipid lowering drugs) 51 (43) 
Overweight (BMI 25-30 kg/m245 (38) 
Obesity (BMI ≥30 kg/m210 (8) 
Combined risk factors  
At least 1 potential metabolic risk factor for liver disease 92 (77) 
Three or more metabolic risk factors with alcohol intake less than 14 units per week 25 (21) 
At least 1 potential risk factor for liver disease (metabolic or alcohol) 96 (81) 
Alcohol consumption n (%) 
AU intake per week 2 (0-35) 
Patient distribution per AU intake per week  
0-6 85 (71) 
7-14 16 (13) 
≥14 14 (12) 
Metabolic  
Type 2 diabetes 8 (6) 
Arterial hypertension 46 (39) 
Dyslipidemia (triglycerides > 150 mg/dL, HDL< 40 mg/dL or need of lipid lowering drugs) 51 (43) 
Overweight (BMI 25-30 kg/m245 (38) 
Obesity (BMI ≥30 kg/m210 (8) 
Combined risk factors  
At least 1 potential metabolic risk factor for liver disease 92 (77) 
Three or more metabolic risk factors with alcohol intake less than 14 units per week 25 (21) 
At least 1 potential risk factor for liver disease (metabolic or alcohol) 96 (81) 

BMI, body mass index.

Close Modal

or Create an Account

Close Modal
Close Modal